CIK 0001618835 · Non-accelerated filer<br>Smaller reporting company
Evofem Biosciences, Inc.
Sign in to watch- Ticker
- EVFM
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208527075
- Phone
- (858) 550-1900
- Business address
- 12400 HIGH BLUFF DRIVE, SUITE 600, SAN DIEGO, CA, 92130
- Former names
- Neothetics, Inc.
- 8-K Event Regulation FD disclosure
- SC 13D/A Stake Beneficial Ownership Report
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- 4 Open-market buy Chief Executive Officer bought 45,249 shares at $2.28 ($103,168)
- UPLOAD Other SEC-generated Letter
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- S-3 Offering Registration Statement
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Regulation FD disclosure
- 4 Grant or award Chief Executive Officer acquired 500,000 shares (grant or award)
Page 15 of 41 · 802 filings